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Dfiversfity off gut mficrolora fis 
requfired ffor the generatfion off B 
cel wfith regulatory propertfies fin a 
skfin grafft model
R. Alhabbab1,*,†, P. Blafir1,*, R. Elgueta1,*, E. Stolarczyk2, E. Marks1, P. D. Becker1, 
K. Ratnasothy1, L. Smyth1, N. Safinfia1, E. Sharfiff-Paghaleh1, S. O’Connel1, R. J. Noele1, 
G. M. Lord1, J. K. Howard2, J. Spencer3, R. I. Lechler1,* & G. Lombardfi1,*
B cels have been reported to promote grafft rejectfion through aloantfibody productfion. However, 
there fis growfing evfidence that B cels can contrfibute to the mafintenance off tolerance. Here, we 
used a mouse model off MHC-class I mfismatched skfin transplantatfion to finvestfigate the contrfibutfion 
off B cels to grafft survfival. We demonstrate that adoptfive transffer off B cels prolongs skfin grafft 
survfival but only when the B cels were fisolated ffrom mfice housed fin low sterfilfity “conventfional” (CV) 
ffacfilfitfies and not ffrom mfice housed fin pathogen ffree ffacfilfitfies (SPF). However, prolongatfion off skfin 
grafft survfival was lost when B cels were fisolated ffrom IL-10 deficfient mfice housed fin CV ffacfilfitfies. 
The suppressfive ffunctfion off B cels fisolated ffrom mfice housed fin CV ffacfilfitfies correlated wfith an 
antfi-finlammatory envfironment and wfith the presence off a dfifferent gut mficrolora compared to 
mfice mafintafined fin SPF ffacfilfitfies. Treatment off mfice fin the CV ffacfilfity wfith antfibfiotfics abrogated the 
regulatory capacfity off B cels. Ffinaly, we fidentfified transfitfional B cels fisolated ffrom CV ffacfilfitfies 
as possessfing the regulatory ffunctfion. These findfings demonstrate that B cels, and fin partficular 
transfitfional B cels, can promote prolongatfion off grafft survfival, a ffunctfion dependent on lficensfing by 
gut mficrolora.
Tere fis a body off evfidence that B cels can contrfibute to alograff rejectfion1–5. In mfice, depletfion off B 
cels has been shown to delay renal alograff rejectfion, and fin humans the finvolvement off B cels fin pro-
motfing graff rejectfion has been suggested by the beneffcfial effects off B cel depletfion therapy (Rfituxfimab) 
ffor kfidney transplant recfipfients3,6,7. However, there fis now also evfidence to suggest that B cels may have 
a role fin promotfing tolerance to alograffs. One study usfing Rfituxfimab as finductfion therapy ffor kfidney 
transplants ffound that the depletfion off B cels led to acute celular rejectfion fin some patfients, suggestfing 
that B cels may contrfibute to alograff survfival by restrafinfing alo-fimmune responses8. We have recently 
reported that fimmunosuppressfive drug ffree transplant patfients who had become spontaneously tolerant 
to thefir HLA mfismatched kfidney transplants had elevated numbers off perfipheral blood B cels and 
upregulated expressfion off several genes assocfiated wfith B cel ffunctfion9. Sfimfilarly, Newel et al. have 
shown that drug ffree tolerant patfients had a hfigher proportfion off transfitfional B cels fin thefir perfipheral 
blood compared to non-tolerant patfients and sfimfilar levels to healthy controls, results that were con-
ffrmed by Sfilva et al.10,11. Further, patfients wfith chronfic graff versus host dfisease ffolowfing alogenefic stem 
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cel transplantatfion have reduced regulatory B cel numbers. However mesenchymal stem cel treatment 
restores Breg ffunctfion, a ffeature whfich correlates wfith an fimproved clfinfical outcome12,13. In mfice, there 
are now multfiple reports that fimplficate a regulatory role ffor B cels fin graff survfival14–20.
In autofimmune models, two major phenotypes off regulatory B cels have been descrfibed, CD5+CD1dhfi 
B10 B cels and CD19+CD21hfiCD23hfiCD24hfi transfitfional-2 (T2) regulatory B cels21. Both have been 
shown to contrfibute to the suppressfion off finffammatfion fin a number off mouse autofimmune models. 
For example, adoptfive transffer off T2 B cels can finhfibfit colagen finduced arthrfitfis (CIA) and lupus21. In 
al these studfies IL-10 was demonstrated to be the major medfiator off thefir ffunctfion22,23. Interestfingly, 
Shfimumura et al. reported that the degree off sterfilfity fin whfich mfice are housed, could alter the ffunc-
tfion off regulatory B cels. B cels could regulate chronfic colfitfis only when the mfice were housed under 
non-hygfienfic condfitfions24. More recently Rosser et al. demonstrated that regulatory B cels had reduced 
abfilfity to prevent experfimental arthrfitfis when fisolated ffrom mfice under sterfile specfiffc pathogen ffree 
(SPF) compared to regulatory B cels fisolated ffrom mfice fin less sterfile conventfional (CV) housfing. 
Ablatfion off gut mficroffora wfith antfibfiotfics treatment ffurther reduced regulatory B cel abfilfity to finhfibfit 
arthrfitfis development25.
Here, we use a mouse model off MHC-class I mfismatched skfin transplantatfion to finvestfigate whether 
sterfilfity off housfing finffuences B cel abfilfity to prolong skfin graff survfival. Adoptfive transffer off B cels fiso-
lated ffrom naïve SPF mfice dfid not prolong skfin transplant survfival and thefir lack off regulatory ffunctfion 
was conffrmed fin vfitro. However, when B cels were fisolated ffrom naïve mfice that had been kept under 
less hygfienfic conventfional (CV) condfitfions, adoptfive transffer off B cels prolonged skfin graff survfival 
and suppressed TNF-α productfion by T cels fin vfitro. In contrast, transffer off B cels ffrom IL-10 deffcfient 
mfice housed fin CV ffacfilfitfies dfid not prolong skfin graff survfival. Also, the regulatory ffunctfion off B cels 
was abolfished by treatment off the mfice wfith antfibfiotfics. Ffinaly, we fidentfiffed that wfithfin total B cels 
the transfitfional B cel subtypes were the subpopulatfions carryfing the regulatory ffunctfion. Tese results 
demonstrate that B cels, and fin partficular transfitfional B cels, acqufire a regulatory role when the mfice 
are kept under non-hygenfic condfitfion and thfis lead to an fincrease fin skfin graff survfival.
Results
B cels fisolated ffrom  mfice  kept fin low sterfilfity conventfional ffacfilfitfies  prolong  MHC-class I 
mfismatched skfin grafft survfival. It has prevfiously been reported that the adoptfive transffer off B cels 
suppresses the development off autofimmunfity fin several murfine models22,23,26 and that B cels may have 
a regulatory ffunctfion fin finducfing graff survfival14–20. In thfis study, the capacfity off B cels to prolong skfin 
transplant survfival was finvestfigated. B cels (1 × 107) enrfiched by negatfive selectfion (> 95% purfity) ffrom 
the spleens off naïve C57BL/6 (B6) mfice housed fin hfigh sterfilfity specfiffc pathogen ffree (SPF) ffacfilfitfies 
were adoptfively transfferred fintravenously (fi.v.) to naïve B6 mfice. One day ffolowfing adoptfive transffer B6 
mfice (H-2b) recefived dorsal skfin transplants ffrom MHC I mfismatched transgenfic B6 mfice that express 
MHC-I H-2Kd (B6-Kd). CD8+ T cels were depleted by fintraperfitoneal (fi.p.) finjectfion off antfi-CD8 antfi-
body on day − 1, 0 (day off skfin graff), + 1 and every 7 days ffolowfing skfin transplant, to elfimfinate the 
contrfibutfion off CD8+ T cels wfith dfirect alospecfiffcfity to graff rejectfion, as prevfiously publfished27. Te 
results fin Ffig.  1a demonstrate that skfin graff survfival was not prolonged by the adoptfive transffer off B 
cels fin SPF ffacfilfitfies.
In a prevfious publficatfion fit was shown that the abfilfity off B cels to finhfibfit chronfic colfitfis, or experfi-
mental arthrfitfis, depended on the sterfilfity off the ffacfilfitfies wfithfin whfich the anfimals were housed25,28. We 
thus tested whether B cels fisolated ffrom mfice housed fin less sterfile conventfional (CV) ffacfilfitfies were 
able to prolong graff survfival. Ffigure 1b demonstrates that adoptfive transffer off 107 B cels fisolated ffrom 
mfice housed fin CV ffacfilfitfies sfignfiffcantly prolonged the survfival off B6-Kd skfin graffs compared to con-
trol mfice. Te prolongatfion off skfin graff survfival observed when B cels were transfferred was off sfimfilar 
extent to the transffer off 5 × 106 graff-specfiffc regulatory T cels (Tregs) fin the same strafin combfinatfion27.
Gfiven that the bacterfial component lfipopolysaccharfide (LPS) has been suggested to be fimportant ffor 
the generatfion off regulatory B cels29,30, and that alterfing the sterfilfity off housfing may affect the amount 
off LPS to whfich B cels are exposed fin vfivo, we finvestfigated whether fincubatfion off SPF B cels wfith LPS 
could restore thefir regulatory ffunctfion. B cels ffrom mfice housed fin the SPF ffacfilfity were pre-fincubated 
fin vfitro wfith LPS ffor 16 hours beffore adoptfive transffer. Ffigure 1c shows that adoptfive transffer off 107 LPS 
treated SPF fisolated B cels to B6 mfice kept fin SPF ffacfilfitfies was able margfinaly to delay graff rejectfion off 
B6-Kd skfin graffs compared to control mfice, however the dfifference dfid not reach statfistfical sfignfiffcance. 
Tfis result suggests that fincreased exposure to LPS stfimulatfion alone does not explafin the enhanced 
regulatory ffunctfion dfisplayed by B cels fisolated ffrom CV ffacfilfitfies and that other ffactors are finvolved.
IL-10 has been shown to be the key cytokfine produced by regulatory B cels fin autofimmune mod-
els21,22. However, fin anfimal models off graff rejectfions the role off IL-10 produced by B cels fin prolongfing 
graff survfivals has been more controversfial16,18–20,31. To test dfirectly whether IL-10 plays any role fin 
the regulatory ffunctfion off B cels, B cels were fisolated ffrom IL-10 deffcfient mfice housed fin efither CV 
ffacfilfitfies (Ffig. 1d) or fin SPF ffacfilfitfies (Ffig. 1e) and thefir abfilfity to prolong graff survfival fin efither ffacfilfity 
was compared to B cels ffrom WT mfice. Prolongatfion off skfin graff survfival was not observed ffolowfing 
transffer off IL-10−/− B cels (Ffig. 1d,e) fisolated ffrom mfice kept fin efither ffacfilfity.
Tese results fin Ffig.  1d,e suggest that IL-10 productfion by B cels fis fimportant ffor the B cel medfi-
ated prolongatfion off skfin graff survfival observed fin CV ffacfilfitfies. However the complete lack off IL-10 fin 
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Ffigure 1. Adoptfive transffer off B cels fisolated ffrom mfice kept fin CV ffacfilfitfies can prolong MHCI 
mfismatched skfin graff survfival. CD8 depleted B6 (H2-Kb) mfice recefived dorsal skfin graffs ffrom B6-Kd (H2-
Kd) mfice. One day prfior to skfin graffs mfice recefived fi.v. finjectfions off 1 × 107 B cels that were FACS purfiffed 
ffrom naïve B6 mfice. Controls recefived PBS. Plots show skfin graff survfival when graff and cel transffer are 
perfformed on mfice kept fin (a) SPF ffacfilfitfies (n ≥ 9/group) and (b) CV ffacfilfitfies. (n ≥ 11/group). (c) B cels 
ffrom naïve B6 mfice mafintafined fin SPF ffacfilfitfies were treated (LPS treated) or not (Untreated) wfith 2 µ g/mL 
LPS ffor 16 hrs. Ten, 1 × 107 B cels were adoptfively transffer one day prfior to skfin graffs, controls recefived 
PBS. Te mfice were kept fin SPF ffacfilfitfies (n ≥ 5/group). (d,e) Injectfions off 1 × 107 B cels that were FACS 
purfiffed ffrom IL-10−/− or WT naïve B6 mfice kept fin CV (d) or SPF (e) ffacfilfitfies. Controls recefived PBS. 
Te adoptfive transffer was made one day prfior to skfin graffs. Plots show skfin graff survfival when graff and 
cel transffer are perfformed on mfice kept fin CV (d) or SPF (e) ffacfilfitfies (n ≥ 6/group ffor each group). (ff,g) 
Plots show skfin graff survfival when cel transffer off 107 B cels ffrom mfice treated wfith antfi-IL10R (aIL-10R) 
antfibody or fisotype control (ISO) fis perfformed on mfice kept fin CV (ff) or SPF (g) ffacfilfitfies (n ≥ 6/group ffor 
each group). Mean survfival fin days fis denoted between parentheses. Statfistfics were calculated by log-rank 
(Mantel-Cox) test + Bonfferonnfi correctfion ffor multfiple comparfisons. *p < 0.05, **p < 0.01.
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IL-10-deffcfient B cel donor mfice mfight fin ffact be finhfibfitfing the development off regulatory B cels. To 
finvestfigate thfis possfibfilfity, IL-10 competent B6 mfice housed fin CV (Ffig.  1ff) or SPF (Ffig.  1g) ffacfilfitfies 
were finjected wfith a neutralfizfing antfibody specfiffc ffor the IL-10 receptor (aIL-10R) or wfith the fisotype 
antfibody (ISO) ffor two weeks. B cels were then purfiffed ffrom these anfimals and transfferred to mfice the 
day beffore recefivfing skfin graffs. We observed that the treatment off mfice wfith aIL-10R antfibody abolfished 
the prolongatfion off skfin transplant survfival obtafined wfith B cels derfived ffrom the ISO group fin CV 
ffacfilfitfies (Ffig.  1ff). Blockade off IL-10R dfid not alter the lack off regulatory ffunctfion observed fin B cels 
fisolated ffrom mfice kept fin SPF ffacfilfitfies (Ffig. 1g). Tese results together suggest that IL-10 appears to be 
necessary ffor the development off regulatory B cels fin vfivo, however fit does not excluded the possfibfilfity 
that IL-10 fis also necessary ffor B cel regulatory ffunctfion.
Mfice  housed  under  non-hygfienfic condfitfions  have  an  actfivated  adaptfive fimmune system. 
Next, we finvestfigated whether there were any fimmunologfical dfifferences between mfice kept fin CV and 
SPF ffacfilfitfies that mfight explafin the dfifference fin the capacfity off B cels to prolong skfin graff survfival. 
Spleens and lymph nodes (LN) were colected ffrom mfice mafintafined fin both ffacfilfitfies, and the pro-
portfions off B and T cel subsets were analysed ex vfivo. No dfifferences were ffound fin total splenfic B 
cels, however, there was a lower percentage off total B cels fin the LN off mfice mafintafined fin CV ffacfilfity 
compared to mfice mafintafined fin the SPF ffacfilfity (Ffig. S1a and S1b). Addfitfionaly, CV mfice dfisplayed 
sfignfiffcantly hfigher percentages off total CD4+, memory (CD62LhfiCD44+) CD4+ and central memory 
CD8+ T cels fin perfipheral LN compared to SPF mfice, whfile lower percentages off CD8+ T cels were 
detected fin the spleens off B6 mfice mafintafined fin SPF ffacfilfity compared to mfice ffrom the CV ffacfilfity 
were observed (Ffig. 2a,b). Tese results suggest an alteratfion fin the B cel:T cel ratfio between the LN off 
anfimals housed fin CV and SPF ffacfilfitfies.
Splenocytes, LN, mesenterfic LN (MLN) and Peyer’s patch (PP) cels were stafined ffor the expressfion 
off CD19, GL-7 and CD95 and germfinal centre (GC) B cels were fidentfiffed by ffow cytometry. As shown 
fin Ffig.  2c mfice housed fin CV ffacfilfitfies had sfignfiffcantly hfigher ffrequencfies and absolute numbers off 
GC B cels fin the MLNs and PPs compared to mfice kept fin SPF ffacfilfitfies. Moreover, there were hfigher 
ffrequencfies and absolute numbers off GC B cels fin the spleens off mfice housed fin CV ffacfilfitfies, however 
the dfifferences were not statficaly sfignfiffcant (Ffig.  2c). Te presence off hfigher numbers off GCs fin the 
spleens off CV mfice compared to SPF mfice was conffrmed by conffocal mficroscopy as Ffig. 2d shown.
Havfing demonstrated dfifferences fin the percentages off memory T cels and fin the levels off GC B cels 
between mfice kept fin the CV and SPF, cytokfine expressfion by B and T cels was finvestfigated. IFN-γ ,
IL-10 and TNF-α expressfion by splenfic B and T cels fisolated ffrom CV and SPF mfice was assessed by 
fintracelular stafinfing ffolowfing 6 hrs stfimulatfion wfith PMA and fionomycfin. Te results fin Ffig. 2e show 
that B cels fisolated ffrom mfice mafintafined fin CV ffacfilfitfies expressed sfignfiffcantly lower levels off IFN-γ 
and TNF-α compared to those fisolated ffrom SPF ffacfilfitfies, wfith no dfifferences fin the productfion off 
IL-10. T cels obtafined ffrom mfice kept fin CV ffacfilfitfies expressed sfignfiffcantly hfigher levels off IL-10 com-
pared to those fisolated ffrom mfice mafintafined fin SPF ffacfilfitfies wfith no major dfifferences fin TNF-α  and 
IFN-γ (Ffig. 2e). Tese results suggest that mfice housed fin less hygfienfic condfitfions have a bfias towards 
a more antfi-finffammatory mficroenvfironment fin the spleen and that both B cels and T cels ffrom mfice 
mafintafined fin the CV ffacfilfitfies have a trend to an hfigher IL-10/TNF-α ratfio compared to the same cel 
types ffrom mfice housed fin the SPF ffacfilfitfies.
Mfice  kept fin  CV ffacfilfitfies  have  an  altered composfitfion  off  gut  mficrobfiota compared  mfice 
housed fin the SPF ffacfilfitfies. Prevfious reports have shown that the presence off commensal mficro-
bfiota affects the development off fimmune responses and can protect humans ffrom atopfic dfiseases32,33. In 
addfitfion, gut mficrobfiota have been shown to finffuence B cel secretfion off fimmunoglobulfin, and support 
the development off splenfic regulatory B cels, suggestfing that the presence off bacterfia fin the gut has a 
measurable fimpact on B cel ffunctfion25,34. Havfing fidentfiffed dfifferences fin the general actfivatfion status 
off the B and T cels off the fimmune system between mfice housed fin the SPF and CV ffacfilfitfies, and fin the 
regulatory potentfial off B cels ffrom CV and SPF mfice, we analysed ffaecal samples to determfine whether 
these dfifferences were assocfiated wfith dfifferences fin thefir gut mficrobfiota. Te data shown fin Ffig.  3a 
demonstrates that the composfitfion off the gut mficrobfiota was sfignfiffcantly dfifferent between mfice housed 
fin CV and SPF ffacfilfitfies. Mfice mafintafined fin CV ffacfilfitfies dfisplayed a reductfion fin the proportfions off 
Lachnospfiraceae (Erec 482+) and Bfiffdobacterfium (Bfiff 164+) groups compared to mfice mafintafined fin SPF 
ffacfilfitfies. To finvestfigate the role off bacterfia fin the finductfion off regulatory B cel ffunctfion, mfice housed 
fin CV ffacfilfitfies were treated ffor 2 weeks wfith broad-spectrum antfibfiotfics. Te effcacy off the antfibfiotfic 
treatment was corroborated by a reductfion off ffaecal mficroffora content by 70% fin the colonfic content 
off antfibfiotfic treated compared to non-treated mfice (Ffig. 3b). It has been prevfiously reported that caecal 
sfize fincreases fin response to augmented hydrated dfietary ffbre components ffolowfing a reductfion fin the 
bacterfial load35. Here, mfice treated wfith antfibfiotfics dfisplayed a marked fincrease fin caecum sfize conffrm-
fing the effcacy off the treatment (Ffig. 3c). We thus tested whether B cel fisolated ffrom antfibfiotfic treated 
mfice housed fin the CV ffacfilfitfies were able to prolong graff survfival. Ffigure 3d shows that, unlfike adoptfive 
transffer off control B cels ffrom non-antfibfiotfic treated mfice, adoptfive transffer off 107 B cels fisolated ffrom 
antfibfiotfic treated mfice housed fin CV ffacfilfitfies was unable to prolong the survfival off B6-Kd skfin graffs. 
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Ffigure 2. Immunologfical dfifferences between mfice kept fin SPF & CV ffacfilfitfies. Spleens, lymph nodes & 
PPs were colected ffrom B6 mfice (6 weeks old) mafintafined fin SPF and CV ffacfilfitfies, and phenotyped ffor B 
cel and T cel populatfions by usfing antfibodfies agafinst CD4, CD8, CD25, CD19, GL7, CD38, CD95, CD44, 
& CD62L. (a) and (b) Hfistograms show mean percentage ± SEM  CD4+, CD8+ and CD4+CD25+ T cels fin 
total splenocytes or total lymph node cels, naïve (CD64LhfiCD44-) and memory (CD62LhfiCD44+) CD4+ T 
cels as percentages off total CD4+ T cels, and naïve and memory CD8+ T cels as percentages off total CD8+ 
T cels fin (a) Spleens and (b) Lymph nodes. (c) Hfistograms show the mean ± SEM off the percentages off GC 
B cels (GL7hfigh and CD95+, leff graph) and absolute number (rfight graph) fin the spleens, MLN and PPs off 
SPF and CV mfice. (d) Immunoffuorescence mficroscopy pfictures off B220 and IgD stafined ffrozen sectfions 
ffrom spleens (top row) and PPs (botom row) off mfice kept fin SPF and CV ffacfilfitfies. Pfictures show B220 
(green) and IgD (Red). Germfinal centres are marked by arrows. (e) Hfistograms show mean ± SEM off IFNγ ,
TNFα , and IL-10 expressfion by splenfic CD4+ T cels and B cels ffolowfing 5 hrs fin vfitro stfimulatfion wfith 
PMA & fionomycfin. n = 3. Statfistfics were calculated by t test, *P < 0.05 & **P < 0.005.
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Ffigure 3. Mfice kept fin CV ffacfilfity have dfifferent composfitfion off mficrobfiota than mfice housed fin SPF 
ffacfilfity. Faecal samples were colected ffrom B6 mfice kept fin SPF & CV ffacfilfitfies, or kept fin CV ffacfilfity 
and treated wfith antfibfiotfics ffor 2 weeks. Dfifferent bacterfial groups (Bac = Bacterofides and Prevotela, 
Erec = Lachnospfiraceae, Bfiff = Bfiffdobacterfium, Lab = Lactobacfilus & Streptococcus) were fidentfiffed by FISH-
Flow. Hfistograms show mean ± SEM ffor (a) proportfions off the domfinant ffecal mficrobfiota fin B6 mfice 
mafintafined fin SPF and CV ffacfilfitfies, and (b) ratfio off total mficrobfiota fin antfibfiotfic treated (ATB) and non-
treated (CV) B6 mfice mafintafined fin CV ffacfilfitfies (the mean total bacterfia fin untreated mfice fis deffned as 
100%). (c) Pfictures off caeca recovered ffrom antfibfiotfics treated and non-treated B6 mfice mafintafined fin CV 
ffacfilfitfies. (d) CD8 depleted B6 (H2-Kb) mfice recefived dorsal skfin graffs ffrom B6-Kd (H2-Kd) mfice. One day 
prfior to skfin graffs mfice recefived fi.v. Injectfions off 1 × 107 B cels that were FACS purfiffed ffrom antfibfiotfics 
(ATB) or control (CV) naïve B6 mfice kept fin CV ffacfilfitfies. Plots show skfin graff survfival when graff and 
cel transffer are perfformed on mfice kept fin SPF ffacfilfitfies. n ≥ 6/group ffor each group. Mean survfival fin days 
fis denoted between parentheses. (e) Hfistograms show mean ± SEM off IFNγ , TNFα , and IL-10 expressfion 
by splenfic CD4+ T cels and B cels ffrom mfice treated wfith antfibfiotfics (ATB) or non-treated (CV) naïve B6 
mfice kept fin CV ffacfilfitfies, 2 findependent experfiments wfith 10 mfice per group. (ff) B cels were fisolated ffrom 
spleens off B6 mfice treated wfith antfibfiotfics or not and mafintafined fin CV ffacfilfitfies. B cels were co-cultured 
wfith CD4+ T cels and firradfiated alo-DCs (25 CD4 T cels:25 B cels:1 alo-DC) ffor 48 hrs. Summary data 
showfing percentage off TNFα supressfion by B cel ffrom spleens off B6 mfice antfibfiotfics treated or non-treated 
and housed fin CV ffacfilfitfies. Hfistograms dfisplay mean ± SEM, 2 findependent experfiments wfith 10 mfice 
per group. Statfistfics were calculated by log-rank (Mantel-Cox) test + Bonfferonnfi correctfion ffor multfiple 
comparfisons and t test, *P < 0.05, **P < 0.005 & ***P < 0.001.
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Al these results together suggest that the fintestfinal mficrobfiota fis essentfial to mafintafin the capacfity off B 
cels to delay skfin graff rejectfion.
We also evaluated whether the antfibfiotfic treatment had an effect on the cytokfine productfion off B 
and T cels. IFN-γ , IL-10 and TNF-α expressfion by splenfic B and T cels fisolated ffrom CV housed 
mfice treated wfith antfibfiotfics, or untreated controls, was assessed by fintracelular stafinfing ffolowfing 4 hrs 
stfimulatfion wfith PMA and fionomycfin. Te results fin Ffig. 3e show that T cels fisolated ffrom mfice treated 
wfith antfibfiotfics expressed sfignfiffcantly hfigher levels off IFN-γ compared to those fisolated ffrom control 
mfice. Both, B and T cels obtafined ffrom mfice treated wfith antfibfiotfics expressed sfignfiffcantly lower levels 
off IL-10 compared to those fisolated ffrom control mfice (Ffig. 3e). To determfine whether the dfifferences 
fin cytokfine productfion between B cels ffrom antfibfiotfics treated and untreated mfice reffected a dfifference 
fin regulatory capacfity, B cel subsets were tested fin vfitro ffor the abfilfity to suppress alo-specfiffc T cel 
actfivatfion. B cels have been shown prevfiously fin autofimmune models to suppress cytokfine productfion 
by CD4+ T cels fin vfitro, fin partficular the expressfion off TNF-α 23. B cel were purfiffed ffrom the spleens 
off CV ffacfilfity housed B6 mfice that had efither been treated wfith antfibfiotfics or ffrom untreated controls, 
and co-cultured wfith CD4+ T cels ffrom spleen off SPF ffacfilfity housed B6 mfice, that had been stfimulated 
by firradfiated H2-Kd expressfing alogenefic dendrfitfic cels (alo-DCs) ffor 48 hours. Our results show that 
ffolowfing stfimulatfion off CD4+ T cels wfith alo-DC, B cels ffrom the spleens off B6 mfice treated wfith 
antfibfiotfics lost the abfilfity to suppress TNF-α expressfion by CD4+ T cel (Ffig. 3ff). Tereffore, we suggest 
that mficrobfiota fis finvolved dfirectly fin empowerfing B cels to suppress T cel responses.
Transfitfional  B cels fisolated ffrom  mfice  kept fin low sterfilfity conventfional ffacfilfitfies  prolong 
MHC-class I  mfismatched skfin  grafft survfival  and suppress  alospecfific TNF-α  expressfion  by 
CD4+ T cel fin vfitro. Next, we finvestfigated whether a partficular subpopulatfion off B cels was respon-
sfible ffor prolongfing skfin graff survfival. No dfifferences were ffound fin the proportfions off the varfious B 
cel subsets fin the spleens off mfice mafintafined fin SPF and CV ffacfilfitfies (Ffig. S1c). To test the abfilfity off 
findfivfidual B cel subsets to prolong graff survfival, transfitfional-1 (T1), transfitfional-2 (T2), ffolficular (FO) 
and margfinal zone (MZ) B cels were sorted by ffow cytometry ffrom the spleens off naïve C57BL/6 (B6) 
mfice housed SPF ffacfilfitfies (Ffig. S2) and 1 × 106 cels off each subset was adoptfively transfferred fintrave-
nously (fi.v.) to naïve B6 mfice. One day ffolowfing adoptfive transffer B6 mfice (H-2b) recefived dorsal skfin 
transplants as descrfibed fin Ffig. 1. As shown fin the Ffig. 1a, none off the B cel subsets ffrom mfice housed 
fin SPF condfitfions were able to prolong skfin graff survfival (Ffig. 4a). We then tested whether any B cel 
subsets fisolated ffrom mfice housed fin CV ffacfilfitfies were able to prolong graff survfival. Ffigure 4b shows 
that adoptfive transffer 1 × 106 T2 B cels, or T1 B cels, sfignfiffcantly prolonged the survfival off B6-Kd skfin 
graffs compared to control mfice when B cel donor were ffrom mfice housed fin CV condfitfions.
To ffurther conffrm the dfifferences fin the regulatory capacfity between transfitfional B cels fisolated ffrom 
mfice housed fin the SPF and CV ffacfilfitfies, B cel subsets were tested fin vfitro ffor the abfilfity to suppress 
alo-specfiffc T cel actfivatfion. B cel subsets were sorted ffrom the spleens off B6 mfice, mafintafined fin the 
SPF and CV ffacfilfitfies and co-cultured wfith CD4+ T cels stfimulated by firradfiated H2-Kd expressfing 
alogenefic dendrfitfic cels (alo-DCs) ffor 48 hours. Our results show that ffolowfing stfimulatfion off CD4+ 
T cels wfith alo-DC, TNF-α expressfion (Ffig.  4c,d) and IFN-γ (Ffig. S3a) by T cels and expressfion off 
CD44 and CD69 molecules (Ffig. S3a) were not altered by any B cel subset ffrom mfice mafintafined fin 
SPF ffacfilfitfies. In contrast, when B cel subsets were fisolated ffrom the spleens off B6 mfice mafintafined fin 
CV ffacfilfitfies, T2 B cels and T1 B cels suppressed TNF-α expressfion by CD4+ T cel by around 40% 
(although ffor T1 B cels the dfifferences dfid not reach statfistfical sfignfiffcance), (Ffig. 4e,ff). Te productfion 
off IFN-γ and the upregulatfion off CD44 and CD69 were mfinfimal and no dfifferences were observed (Ffig. 
S3b). No other B cel subset suppressed alo-specfiffc TNF-α expressfion by CD4+ T cels. In terms off 
the cytokfines produced by the dfifferent B cel subsets derfived ffrom CV ffacfilfity we observed that IL-10 
expressfion by B cels and suppressfive capacfity dfid not correlate, as MZ B cels expressed more IL-10 than 
other B cel subsets even though they dfid not suppress T cel TNF-α expressfion (Ffig. 4g). A sfimfilar IL-10 
proffle was observed fin the dfifferent B cel subsets derfived ffrom mfice house fin the SPF ffacfilfity (data not 
shown). Tereffore, we suggest that IL-10 produced by B cels fis only partfialy finvolved to supress the T 
cel response as we have prevfiously demonstrated20.
Next, we evaluated whether treatment off CV housed mfice wfith antfibfiotfics altered the fin vfitro sup-
pressfive capacfity off the dfifferent B cel subsets. Ffigure 4h shows that IL-10 levels were drastficaly reduced 
fin the supernatants off co-cultures between CD4+ T cels, ffrom spleen off mfice housed fin SPF ffacfilfitfies, 
and T2, or T1, B cels fisolated ffrom CV housed mfice treated wfith antfibfiotfics compared wfith B cels 
fisolated ffrom control untreated mfice (Ffig. 4h). Tese results correlated wfith the reductfion fin the IL-10+ 
B cels ffound ex-vfivo and fin the percentages off suppressfion fin vfitro (Ffig. 3e,ff). Tese results suggest that 
antfibfiotfic treatment reduces the abfilfity off T2 and T1 B cels to finduce regulatory cytokfine productfion fin 
finteractfions wfith CD4+ T cels.
Dfiscussfion
In thfis study we have demonstrated that B cels acqufire the capacfity to prolong skfin graff survfival 
when the mfice are housed under non-hygfienfic condfitfions. We have shown that B cel regulatory ffunc-
tfion and abfilfity to prolong alograff survfival correlate wfith the presence off gut mficrobfiota and thus, 
antfibfiotfics-treatment abolfished the regulatory ffunctfion off B cels. In addfitfion, we observed that mfice kept 
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Ffigure 4. Adoptfive transffer off T2 B cels fisolated ffrom mfice kept fin CV ffacfilfitfies can prolong MHC I 
mfismatched skfin graff survfival. CD8 depleted B6 (H2-Kb) mfice recefived dorsal skfin graffs ffrom B6-Kd 
(H2-Kd) mfice. One day prfior to skfin graffs mfice recefived fi.v. Injectfions off 1 × 106 T2, T1, FO, or MZ B cels 
that were FACS purfiffed ffrom naïve B6 mfice. Controls recefived PBS. Plots show skfin graff survfival when 
graff and cel transffer are perfformed on mfice kept fin (a) SPF ffacfilfitfies (n ≥ 6/group ffor each experfiment) 
and (b) CV ffacfilfitfies. (n ≥ 8/group ffor each experfiment). Mean survfival fin days fis denoted between 
parentheses. Statfistfics were calculated by log-rank (Mantel-Cox) test + Bonfferonnfi correctfion ffor multfiple 
comparfisons. (C–G) B cels were fisolated ffrom spleens off B6 mfice mafintafined fin SPF (c,d) or CV (E-G) 
ffacfilfitfies by magnetfic sortfing. B cel subsets were purfiffed by FACS and co-cultured wfith negatfively fisolated 
CD4+ T cels and firradfiated alo-DCs (25 CD4 T cels:25 B cels:1 alo-DC) ffor 48 hrs. PMA, Ionomycfin 
and breffeldfin A were added ffor the last 4 hours off culture. (c and e) Representatfive FACS plots off CD4+ 
T cel TNF-α expressfion, (d and ff) summary data showfing CD4+ T cels TNF-α expressfion, (g) summary 
data showfing IL-10 expressfion by B cel subsets fisolated ffrom spleens off B6 mfice housed fin CV ffacfilfity. 
Hfistograms dfisplay mean ± SEM, (n = 3). (h) Summary data showfing IL-10 secretfion fin cultures off T cel 
alone and wfith each subset off B cels ffrom mfice treated wfith antfibfiotfics (ATB) or salfine solutfion (CV) 
and kept fin CV ffacfilfitfies. Statfistfics were calculated by one-way ANOVA and Bonfferronfi post-test, ns- not 
sfignfiffcant, *P < 0.05, **P < 0.005, ***P = 0.0005.
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fin CV ffacfilfitfies had an fincrease fin memory T cels fin the LN(s), a hfigher numbers off GC B cel and an 
apparent bfias towards an antfi-finffammatory mficroenvfironment. Furthermore, we observed that B cels 
derfived ffrom IL-10−/− mfice dfid not prolong skfin graff survfival. Ffinaly, we provfide evfidence that among 
the dfifferent B cel subsets the regulatory ffunctfion fis fin the transfitfional B cel subsets.
It has been wel demonstrated by us and others that adoptfive transffer off Tregs has the capacfity to 
finduce transplant tolerance27,36–39. We have prevfiously shown that the adoptfive transffer off 5 × 106 Tregs 
wfith findfirect specfiffcfity ffor the graff, confferred by TCR transductfion, to C57BL/6 mfice recefivfing a 
MHC-class I mfismatched skfin graffs has the capacfity to prolong skfin graff survfival ffor 9 days27. In 
the experfimental model presented here usfing the same strafin combfinatfion, the adoptfive transffer off 107 
autologous B cels, and as ffew as 1 × 106 T2 and T1 B cels, was capable off finducfing a sfignfiffcant pro-
longatfion off B6-Kd skfin graff survfival compared to controls (> 4 days). Tese results suggest that the 
adoptfive transffer off B cels fis almost as powerfful as the adoptfive transffer off aloantfigen specfiffc Tregs ffor 
prolongfing skfin transplant survfival.
Recently, fit has been reported that the adoptfive transffer off 107 TIM-1+ B cels was capable off pro-
longfing the survfival off pancreatfic fislet alograffs fin B cel deffcfient (JHD mfice) transplant recfipfients14. 
In thfis model TIM-1+ B cels were generated by efither treatment off donor mfice wfith antfi-TIM-1 antfi-
body or by the presence off an alograff, however the adoptfive transffer off TIM-1+ B cels fisolated ffrom 
naïve mfice dfid not prolong fislet graff survfival14. It fis possfible that fiff TIM-1+ B cels were fisolated ffrom 
naïve mfice kept fin non-sterfile condfitfions then they may possess regulatory potentfial wfithout prfior fin 
vfivo actfivatfion. Low level actfivator sfignals assocfiated wfith the presence off commensal mficrobfiota may 
play a sfimfilar role to the finffammatfion assocfiated wfith the presence off an alograff and lficense B cels to 
achfieve a regulatory potentfial. It has been prevfiously reported that B cels must be actfivated to have fful 
regulatory potentfial21,26.
Te fimportance off envfironmental mficroorganfisms ffor B cel ffunctfion fin vfivo was demonstrated by a 
recent study where B cels fisolated ffrom the spleens and PPs off mfice kept fin a CV ffacfilfity secreted hfigher 
levels off antfibody than mfice kept fin germ ffree ffacfilfitfies34. Sfimfilarly, we observed that housfing mfice under 
non-hygfienfic condfitfions resulted fin fincreased number off GC B cels, changes to the cytokfine productfion 
off B cels ffolowfing restfimulatfion fin vfitro (Ffig. 2e). Tus, our data supports the fidea that the presence off 
envfironmental mficroorganfisms can shape the murfine B cel response.
Te fimportance off mficrobfiota ffor the development off B cels wfith regulatory ffunctfion fin our study 
agrees wfith the prevfious reports off Shfimomura et al. and Rosser et al.25,28 lfinked perfitoneal CD5− B-1 B 
cel medfiated protectfion ffrom colfitfis to the housfing condfitfions off the mfice, whfile Rosser et al. recently 
demonstrated that the presence off gut mficrobfiota fis crucfial ffor the development off splenfic regulatory 
T2-MZP Bregs25,28. Here we extend these results and demonstrate that the gut mficrobfiota are also crucfial 
ffor generatfing T2 regulatory B cel abfilfity to suppress alo-fimmune responses. Interestfingly, Shfimomura 
et al. ffound no role ffor IL-10 productfion by thefir proposed perfitoneal regulatory B cels whfile Rosser 
et al. ffound fit was necessary ffor splenfic regulatory B cel ffunctfion.
Prevfious studfies fin autofimmune models have provfided evfidence ffor the role off IL-10 fin the ffunctfion 
off regulatory B cels. In our study, we ffound no dfifference fin IL-10 productfion between B cels fisolated 
ffrom CV and SPF mfice fin vfitro nor dfid we ffnd a correlatfion between B cel subset IL-10 productfion and 
regulatory capacfity. However, although ffrequency off IL10+ B cels ffrom CV and SPF mfice are the same, 
the percentages off TNF-α + B cels are hfigher fin cels derfived ffrom the SPF compared to CV ffacfilfitfies, 
suggestfing fit fis the ratfio off pro-finffammatory to antfi-finffammatory cytokfine productfion that may be 
fimportant fin decfidfing whether B cel transffer delays graff rejectfion or not (Ffig.  1ff). Tfis hypothesfis fis 
supported by the recent results fin human renal transplant recfipfients fin whfich the authors demonstrate 
that the ratfio off IL-10 and TNF-α expressfion fis more fimportant than IL-10 expressfion alone ffor meas-
urfing the ffunctfion off regulatory B cels40.
A dfirect role ffor IL-10 fin thfis skfin transplant model was demonstrated by the finabfilfity off B cels fiso-
lated ffrom IL-10−/− mfice, or mfice pretreated wfith blockfing antfi-IL-10R antfibody, to prolong skfin graff 
survfival on adoptfive transffer (Ffig. 1d,ff). Tese results suggest that, whfile IL-10 expressfion alone fis not 
suffcfient to fidentfiffy regulatory B cels, fits productfion may potentfialy be fimportant ffor thefir development 
fin naïve mfice and thefir subsequent abfilfity to prolong skfin graff survfival. In transplant models the role 
played by B cel IL-10 productfion fis stfil controversfial9,10,14,41. Whfile the fimportance off IL-10 expressfion 
to the abfilfity off TIM-1+ B cels to prolong pancreatfic fislet alograff survfival has been demonstrated14 
other studfies have been unable to fidentfiffy a role ffor B cel IL-10 productfion fin transplant tolerance9,10,41. 
In humans, three recent publficatfions that reported an assocfiatfion off B cels wfith tolerance to kfidney 
transplants fin humans dfid not report an assocfiatfion wfith IL-10 mRNA transcrfiptfion9,10,41. In mfice, stud-
fies off the capacfity off antfi-CD45RB monotherapy to finduce tolerance to cardfiac alograffs reported that, 
whfile thfis tolerance protocol was dependent on the presence off B cels, IL-10 productfion by B cels was 
counter-regulatory and that IL-10 neutralfizatfion fimproved graff outcome42.
Some off the sfignals that medfiate the effect off mficrobfiota on regulatory B cel ffunctfion have been 
recently fidentfiffed25. IL-1β and IL-6 produced by monocytes and dendrfitfic cels has been suggested to be 
responsfible ffor mficrobfiota medfiated regulatory B cel finductfion; the presence off gut mficrobfiota no longer 
has the abfilfity to generate T2-MZP Bregs fin vfivo fiff the B cels specfiffcaly do not express efither off these 
receptors25. TLR lfigatfion by mficrobfial antfigens ffor finstance may also play a role; fit has been reported that 
TLR agonfists can dfirectly stfimulate B cels to produce cytokfines and antfibodfies43, and TLR lfigands have 
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been suggested to be the major stfimulfi finvolved fin the actfivatfion off B10 regulatory B cels21,26. However, 
fin our study LPS-treatment off B cels derfived ffrom the SPF ffacfilfity dfid not finduce regulatory ffunctfion fin 
B cels. It fis possfible that other celular target off LPS, or other ffactors together wfith LPS, can contrfibute 
to the acqufisfitfion by B cels off regulatory ffunctfion.
In conclusfion, the data presented here findficate that bacterfia could shape B cel regulatory ffunctfion. 
Tfis fis consfistent wfith the ‘hygfiene hypothesfis’ that lfinks abfilfity to tolerate alergens to prfior exposure 
to a spectrum off envfironmental antfigens33. We suggest that abfilfity to tolerate alograffs may be sfimfilarly 
enhanced by regulatory B cels that have been condfitfioned by bacterfial antfigens or metabolfites derfived 
ffrom the fintestfinal mficrobfiota. More work fis needed to understand the mechanfisms behfind the outcome 
observed fin our model.
Materfial & Methods
Ethfics  Statement. Tese studfies were approved and conducted fin accredfited ffacfilfitfies fin accord-
ance wfith Te Home Offce UK Anfimals (Scfientfiffc Procedures) Act 1986 (Home Offce lficense number 
PPL 70/7302).
Mfice. Wfild type (WT) C57BL/6 (H-2b) mfice and BALB/c (H-2d) mfice were purchased ffrom Harlan 
Laboratory. B6Kd mfice were a generous gfiff ffrom Dr. R Pat Bucy (Unfiversfity off Alabama at Bfirmfingham, 
Bfirmfingham, AL, USA). IL-10−/− mfice were kfindly provfided by Anne O’Garra (NIMR, London). Mfice 
were mafintafined fin specfiffc pathogen ffree (SPF) or conventfional (CV) ffacfilfitfies. In some exprerfiments, 
mfice house fin CV ffacfilfity were finjected every 3 days ffor 2-3 weeks wfith 300 µ g/mouse wfith antfi-mouseIL-
10R (clone 1B1.3A, BfioXcel). In other experfiments, mfice kept fin CV ffacfilfitfies were treated wfith antfibfiot-
fics as descrfibed44. Alteratfions are as noted: ampficfilfin (0.5 g/l; Roche, UK), vancomycfin (0.5 gm/l; Sfigma, 
UK), neomycfin sulffate (0.5 g/l; Sfigma, UK), and metronfidazole (0.5 g/l; Sfigma) were dfissolved fin ffltered 
drfinkfing water and ffufid fintake was monfitored. Tese studfies and experfimental protocols were approved 
and conducted fin accredfited ffacfilfitfies fin accordance wfith Te Home Offce UK (Scfientfiffc Procedures) 
Act 1986 (Home Offce lficense number PPL 70/7302) and Kfing’s Colege London.
Antfibodfies and Flow Cytometry. Al FACS antfibodfies were purchased ffrom eBfioscfience. For fimmu-
nohfistochemfistry FITC-conjugated antfi-B220 mAb and bfiotfinylated antfi-IgD were purchased ffrom eBfio-
scfiences streptavfidfin-conjugated alexaffuor594 was purchased ffrom Molecular Probes. Surfface stafinfings 
were perfformed as prevfiously descrfibed45. For fintracelular stafinfing, cels were stafined then ffxed/perme-
abfilfized accordfing to the eBfioscfience protocol. Permeabfilfized cels were fincubated fin Permwash™  wfith antfi-IL10, antfi-TNF, or approprfiate fisotype control ffor 30 mfins at 4 °C (wfith blockfing antfi-CD16/32). 
Intracelular stafinfing ffor FOXP3 was perfformed wfith eBfioscfience FOXP3 kfit accordfing to manuffacturer’s 
finstructfions. For the detectfion off fintracelular cytokfines PMA (50 ng/ml), fionomycfin (1 µ M) and breffel-
dfin A were added ffor 5 hrs beffore stafinfing. Cels were acqufired usfing LSRII or Fortessa ffow cytometers 
(BD Bfioscfiences). Flow Jo soffware was used ffor analysfis.
Purfificatfion  off  B cels,  B cel subsets  and CD4+ T cels. B cels were purfiffed ffrom the spleens 
off IL-10−/− or C57BL/6 mfice by negatfive selectfion usfing CD43 mficrobeads (Mfiltenyfi Bfiotech, 130-049-
801) accordfing to manuffacturer’s finstructfions. Purfiffed splenfic B cels were stafined wfith antfi-CD21, 
antfi-CD24 antfi-CD23. DAPI was added to exclude dead cels. Cels were sorted by BD FACSArfia II (BD 
Bfioscfiences). CD4+ T cels were fisolated ffrom the spleens off C57BL/6 mfice usfing Invfitrogen Dynabeads® Untouched™ Mouse CD4 Cels kfits, accordfing to manuffacturer’s finstructfions (Invfitrogen, 11416D).
B cel stfimulatfion wfith LPS. B cels ffrom spleen were culture at a densfity off 106/mL wfith or wfithout 
LPS ffrom E. colfi serotype EH100 (TLR grade) (ALX-581-01-L002) at a ffnal concentratfion off 2 µ g/ml ffor 
16 hrs at 37 °C, 5%CO2. Cels were then washed and resuspend at a concentratfion off 5 × 107 ml fin salfine. Mfice were finjected fi.v. wfith 107 cels fin 200 µ l.
DC  generatfion. DCs were generated ffrom bone marrow as prevfiously descrfibed45. One day beffore 
usfing the DCs, 100 ng/mL LPS (E. colfi, Enzo Lfiffe Scfiences, UK) was added to finduce maturatfion. At day 
7 off culture, DCs were colected, washed three tfimes, and firradfiated.
Skfin transplants. Donor tafil skfin graffs were perfformed and monfitored as prevfiously descrfibed45. 
Antfi-CD8 antfibody (clone YTS169, 250 µ g/finjectfion/mouse) was finjected fi.p. at day-1 and day 1 affer 
skfin graff, and weekly thereaffer.
In vfitro suppressfion assays. Isolated CD4+ T cels were co-cultured wfith firradfiated alo-DCs alone 
at a ratfio off 25 T cels:1 DC, or wfith B cels and alo-DCs at a ratfio off 25 T cels: 25 B cels: 1 DC. Cels 
were cultured ffor 48 hrs at 37 °C fin RPMI fin 96 wel plates (1.5–2 × 105 cels/wel).
Immunohfistochemfistry. Tfissues were embedded fin OCT compound (TfissueTek) and snap-ffrozen 
fin lfiqufid nfitrogen. Frozen sectfions (7 µ m) were ffxed fin 50% acetone ffor 30 seconds and 100% acetone 
ffor 5 mfin at 4 °C and then afir-drfied at room temperature. Te tfissue sectfions were blocked wfith normal 
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horse serum fin PBS (5%) ffor 15 mfin. Te sectfions were stafined ffor 30–60 mfins wfith FITC-conjugated 
antfi-B220 mAb and bfiotfinylated antfi-IgD, ffolowed by streptavfidfin-conjugated alexaffuor594. Te slfides 
were then washed fin PBS, mounted wfith ffuorescent mountfing medfium (Vector), vfisualfised on a ffuores-
cent mficroscope and analysed usfing mficroscope manager and Image J. Al fimages are 10× magnfiffcatfion.
Antfibfiotfic Treatment. Mfice were treated as descrfibed44. Alteratfions are as noted: ampficfilfin (0.5 g/l; 
Roche, UK), vancomycfin (0.5 gm/l; Sfigma, UK), neomycfin sulffate (0.5 g/l; Sfigma, UK), and metronfida-
zole (0.5 g/l; Sfigma) were dfissolved fin ffltered drfinkfing water and ffufid fintake was monfitored.
Fluorescent fin-sfitu  hybrfidfizatfion (FISH-Flow). Stool samples were colected and stored at 
− 80 °C. Fluorescent fin sfitu hybrfidfisatfion (FISH) combfined wfith ffow cytometry was perfformed as 
prevfiously descrfibed wfith mfinor modfiffcatfions46. Faeces (0.05 g) were homogenfised fin 0.5 ml off sterfile 
phosphate-buffered salfine (PBS, 130 mM NaCl, 3 mM NaH2PO4 2H2O, 7 mM Na2HPO4 12H2O, pH 7.2) wfith 5 glass beads fin the Tfissue Lyser (Qfiagen, UK) ffor 5 mfin at 25 Hz. One volume off the suspensfion 
was added to 3 volumes off 4% parafformaldehyde (PFA) fin PBS. Affer overnfight ffxatfion at 4 °C, the 
ffxed suspensfion fin PFA was stored at − 80 °C untfil hybrfidfisatfion. Te EUB 338 probe was used as the 
posfitfive control probe, the NON 338 probe as the negatfive control and specfiffc probes ffor fidentfiffcatfion 
off sub-groups (Ffig. S4). Al probes were covalently lfinked at thefir 5′ end efither to ffuorescefin fisothfiocy-
anate (FITC) or to the sulffofindocyanfine dye findodficarbocyanfine (Cy5) as findficated (Ffig. S4). Samples 
were acqufired by ffow cytometry (HTS Fortessa, Becton Dfickfinson, USA). Subsequent analyses were 
conducted usfing FlowJo soffware (Tree Star, USA).
Statfistfical  analysfis. Comparfisons between groups were perfformed usfing T-test ffor two groups, 
or one-way ANOVA and a Dunnet or Bonfferronfi post-test ffor more than two groups. Log Rank 
(Mantel-Cox) tests were used ffor graff survfival curves. Analyses were perfformed usfing GraphPad Prfism 
soffware.
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